Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy

MLA

Haijie Han, et al. “Emerging Pro-Drug and Nano-Drug Strategies for Gemcitabine-Based Cancer Therapy.” Asian Journal of Pharmaceutical Sciences, vol. 17, no. 1, Jan. 2022, pp. 35–52. EBSCOhost, https://doi.org/10.1016/j.ajps.2021.06.001.

APA

Haijie Han, Su Li, Yueyang Zhong, Yue Huang, Kai Wang, Qiao Jin, Jian Ji, & Ke Yao. (2022). Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy. Asian Journal of Pharmaceutical Sciences, 17(1), 35–52. https://doi.org/10.1016/j.ajps.2021.06.001

Chicago

Haijie Han, Su Li, Yueyang Zhong, Yue Huang, Kai Wang, Qiao Jin, Jian Ji, and Ke Yao. 2022. “Emerging Pro-Drug and Nano-Drug Strategies for Gemcitabine-Based Cancer Therapy.” Asian Journal of Pharmaceutical Sciences 17 (1): 35–52. doi:10.1016/j.ajps.2021.06.001.